St. Johns Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
ABSI Stock | USD 2.99 0.16 5.08% |
Under 67% of Absci Corp's investor base is looking to short. The analysis of the overall investor sentiment regarding Absci Corp suggests that many traders are alarmed. Absci Corp's investing sentiment shows overall attitude of investors towards Absci Corp.
Absci |
Abscis generative AI and wet lab capabilities combined with St. Johns Cancer Institutes molecular database of cancer patient specimens will accelerate the development of immunotherapies. VANCOUVER, Wash. and NEW YORK, Feb. 09, 2023 -- Absci Corporation , a generative AI drug creation company, and St. Johns Cancer Institute , a pioneer in cancer care, research and innovation, today announced they have entered into a partnership to uncover breakthrough canc
Read at finance.yahoo.com
Absci Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Absci Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Absci Corp Fundamental Analysis
We analyze Absci Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Absci Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Absci Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Absci Corp is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Absci Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Absci Corp stock to make a market-neutral strategy. Peer analysis of Absci Corp could also be used in its relative valuation, which is a method of valuing Absci Corp by comparing valuation metrics with similar companies.
Peers
Absci Corp Related Equities
RXRX | Recursion Pharmaceuticals | 7.21 | ||||
DAWN | Day One | 1.81 | ||||
ABOS | Acumen Pharmaceuticals | 2.98 | ||||
ZURA | Zura Bio | 3.57 | ||||
HEPA | Hepion Pharmaceuticals | 4.76 | ||||
XFOR | X4 Pharmaceuticals | 5.13 | ||||
RLAY | Relay Therapeutics | 6.00 | ||||
INZY | Inozyme Pharma | 6.09 | ||||
ELEV | Elevation Oncology | 8.06 | ||||
CRBU | Caribou Biosciences | 8.44 | ||||
DTIL | Precision BioSciences | 9.61 | ||||
SANA | Sana Biotechnology | 9.82 | ||||
AFMD | Affimed NV | 10.43 |
Complementary Tools for Absci Stock analysis
When running Absci Corp's price analysis, check to measure Absci Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Absci Corp is operating at the current time. Most of Absci Corp's value examination focuses on studying past and present price action to predict the probability of Absci Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Absci Corp's price. Additionally, you may evaluate how the addition of Absci Corp to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |